Funder: Breakthrough T1D
Due Dates (Anticipated): February 2026 (Full application) | May 2026 (Funding decision)
Funding Amounts: Up to $200,000 USD/year (including up to 10% indirect costs) for up to 5 years; not generally renewable after 5 years.
Summary: Supports early-career faculty in type 1 diabetes research with funding to establish independent careers in Breakthrough T1D priority areas.
Key Information: Applications focused on long-term complications are not accepted; clinical, basic, and psychosocial/behavioral health projects are eligible.